Dissolution behavior of commercial enteric‐coated aspirin tablets

7Citations
Citations of this article
2Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Dissolution behavior was studied for four commercial batches of enteric‐coated aspirin tablets from two companies. The USP XIX dissolution procedure was modified by including pretreatment in simulated gastric juice. The effects of five pretreatment times were studied. Pretreated tablets yielded higher dissolution profiles and fewer undissolved fractions than nonpretreated tablets. Among pretreatments, 15 min was adequate and 60 min produced the highest dissolution profiles. None of the pretreatments differed significantly from each other. An F test conducted on the data indicated that Product × was significantly better than Product Y at the p = 0.05 level. Batch C was ranked as the best batch irrespective of pretreatment time, followed by Batch D. Batches A and B were equal, although Batch A appeared to be better than B for the (60‐min pretreatment, as indicated by the lower t80% value. Copyright © 1979 Wiley‐Liss, Inc., A Wiley Company

Cite

CITATION STYLE

APA

Embil, K., & Torosian, G. (1979). Dissolution behavior of commercial enteric‐coated aspirin tablets. Journal of Pharmaceutical Sciences, 68(10), 1290–1292. https://doi.org/10.1002/jps.2600681024

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free